INDRAPRASTHA MEDICAL CORPORATION
|
|
BOM : 532150     NSE : INDRAMEDCO     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 19,2022 |
Price(EOD): ₹ 57.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 525.90 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
INDRAPRASTHA MEDICAL CORPORATION | -1.7% | -14.5% | -19.9% |
APOLLO HOSPITALS ENTERPRISE | 2.4% | -24.6% | 18.6% |
MAX HEALTHCARE INSTITUTE | 1% | -0.6% | 66.1% |
DR LAL PATHLABS | -16.1% | -29.4% | -25.5% |
FORTIS HEALTHCARE | -0.6% | -13.3% | 7.3% |
METROPOLIS HEALTHCARE | -12.1% | -27.1% | -24% |
ASTER DM HEALTHCARE | -1% | -7.5% | 14.7% |
NARAYANA HRUDAYALAYA | -2.3% | -9.3% | 50.1% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.8% | -10.3% | NA |
FUNDAMENTAL ANALYSIS OF INDRAPRASTHA MEDICAL CORPORATION
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF INDRAPRASTHA MEDICAL CORPORATION
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
229.4
P/E Calculated based on EPS of 0.25
[ Mar2021 - Standalone Results ] 1.93
P/B Calculated based on Book Value of 29.75
[ Mar2021 - Standalone Results ] 0.6
P/S Calculated based on Revenues of 870.488 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-32% -33% -22% |
SHARE PRICE MOMENTUM OF INDRAPRASTHA MEDICAL CORPORATION
INDRAPRASTHA MEDICAL CORPORATION vs SENSEX
DEBT OF INDRAPRASTHA MEDICAL CORPORATION
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0.01 0.09 0.03 |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF INDRAPRASTHA MEDICAL CORPORATION
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF INDRAPRASTHA MEDICAL CORPORATION
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
1.6% 23.43% 36.95% 31.9% |
31.44% 20.54% 32.04% 32.82% |
QtrlyTrend |
8 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
INDRAPRASTHA MEDICAL CORPORATION related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 3.2% | -11.7% | 16.2% |
S&P BSE MIDSMALLCAP | 2.7% | -11.3% | 12.2% |
S&P BSE HEALTHCARE | 1.2% | -9.9% | -7.6% |
S&P BSE ALLCAP | 0.8% | -9.3% | 9.3% |
You may also like the below Video Courses
FAQ about INDRAPRASTHA MEDICAL CORPORATION
Is INDRAPRASTHA MEDICAL CORPORATION good for long term investment?
As on May 19,2022, the Fundamentals of INDRAPRASTHA MEDICAL CORPORATION look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of INDRAPRASTHA MEDICAL CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is INDRAPRASTHA MEDICAL CORPORATION UnderValued or OverValued?
As on May 19,2022, INDRAPRASTHA MEDICAL CORPORATION is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION ?
As on May 19,2022, the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION is Rs. 84.10 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 84.10
Fair Value [Median EV / Sales Model] : Rs. 86.23
Fair Value [Median Price / Sales Model] : Rs. 73.46
Median Fair Value of INDRAPRASTHA MEDICAL CORPORATION : Rs. 84.10
Is INDRAPRASTHA MEDICAL CORPORATION trading at a Premium or Discount?
As on May 19,2022, INDRAPRASTHA MEDICAL CORPORATION is trading at a Discount of -32% based on the estimates of Median Intrinsic Value!APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs DR LAL PATHLABS LTD
FORTIS HEALTHCARE LTD vs METROPOLIS HEALTHCARE LTD vs ASTER DM HEALTHCARE LTD
NARAYANA HRUDAYALAYA LTD vs KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD vs THYROCARE TECHNOLOGIES LTD
SHALBY LTD vs KOVAI MEDICAL CENTER & HOSPITAL LTD vs KMC SPECIALITY HOSPITALS (INDIA) LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs KAYA LTD vs ARTEMIS MEDICARE SERVICES LTD
